Change search
ReferencesLink to record
Permanent link

Direct link
Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus
FIND, 9 Chemin Mines, CH-1202 Geneva, Switzerland..
FIND, 9 Chemin Mines, CH-1202 Geneva, Switzerland.;WHO, Special Programme Res & Training Trop Dis TDR, Ave Appia 20, CH-1211 Geneva 27, Switzerland.;Hawassa Univ, Dept Pediat, Coll Med & Hlth Sci, Hawassa, Ethiopia..
WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland..
Tan Took Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore..
Show others and affiliations
2016 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 11, no 8, e0161721Article in journal (Refereed) Published
Abstract [en]

Acute fever is one of the most common presenting symptoms globally. In order to reduce the empiric use of antimicrobial drugs and improve outcomes, it is essential to improve diagnostic capabilities. In the absence of microbiology facilities in low-income settings, an assay to distinguish bacterial from non-bacterial causes would be a critical first step. To ensure that patient and market needs are met, the requirements of such a test should be specified in a target product profile (TPP). To identify minimal/optimal characteristics for a bacterial vs. non-bacterial fever test, experts from academia and international organizations with expertise in infectious diseases, diagnostic test development, laboratory medicine, global health, and health economics were convened. Proposed TPPs were reviewed by this working group, and consensus characteristics were defined. The working group defined non-severely ill, non-malaria infected children as the target population for the desired assay. To provide access to the most patients, the test should be deployable to community health centers and informal health settings, and staff should require <2 days of training to perform the assay. Further, given that the aim is to reduce inappropriate antimicrobial use as well as to deliver appropriate treatment for patients with bacterial infections, the group agreed on minimal diagnostic performance requirements of >90% and >80% for sensitivity and specificity, respectively. Other key characteristics, to account for the challenging environment at which the test is targeted, included: i) time-to-result <10 min (but maximally <2 hrs); ii) storage conditions at 0-40 degrees C, <= 90% non-condensing humidity with a minimal shelf life of 12 months; iii) operational conditions of 5-40 degrees C, <= 90% non-condensing humidity; and iv) minimal sample collection needs (50-100 mu L, capillary blood). This expert approach to define assay requirements for a bacterial vs. non-bacterial assay should guide product development, and enable targeted and timely efforts by industry partners and academic institutions.

Place, publisher, year, edition, pages
2016. Vol. 11, no 8, e0161721
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:uu:diva-307303DOI: 10.1371/journal.pone.0161721ISI: 000382258600087OAI: oai:DiVA.org:uu-307303DiVA: diva2:1046008
Available from: 2016-11-11 Created: 2016-11-11 Last updated: 2016-11-11Bibliographically approved

Open Access in DiVA

fulltext(240 kB)33 downloads
File information
File name FULLTEXT01.pdfFile size 240 kBChecksum SHA-512
b49de2de4c68f0614844cc4a4aad74671bacc8bae62ca1bf5fab49f4f146b9b188e9843b43b18241f289d3e876d44158fc123ec49d9240750917a8e7daa06f1c
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Zorzet, AnnaTängdén, Thomas
By organisation
Department of Medical Sciences
In the same journal
PLoS ONE
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 33 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 26 hits
ReferencesLink to record
Permanent link

Direct link